Skip to main content
Erschienen in: World Journal of Surgery 11/2018

11.05.2018 | Original Scientific Report

Impact of Biliary Drainage on Multidetector-Row Computed Tomography on R0 Resection of Perihilar Cholangiocarcinoma

verfasst von: Isamu Hosokawa, Hiroaki Shimizu, Hideyuki Yoshitomi, Katsunori Furukawa, Tsukasa Takayashiki, Masaru Miyazaki, Masayuki Ohtsuka

Erschienen in: World Journal of Surgery | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Although multidetector-row computed tomography (MDCT) before biliary drainage is useful for the assessment of the resectability of perihilar cholangiocarcinoma (PHC), the impact of biliary drainage on MDCT images before surgical resection for PHC has been poorly studied, and its possible consequences for R0 resection of PHC remain unclear. This study was performed to compare the surgical outcomes of patients with PHC who underwent MDCT before versus after biliary drainage.

Methods

All consecutive patients who underwent major hepatectomy extending to segment 1 with extrahepatic bile duct resection for PHC from 2009 to 2016 were retrospectively evaluated. R0 resection was defined as no residual cancer at all surgical margins. Patients with pathological stage IV PHC were excluded.

Results

Of 142 patients who underwent major hepatectomy, 108 were eligible for this study. Of these 108 patients, 64 (59%) and 44 (41%) underwent MDCT before and after biliary drainage, respectively. The total bilirubin concentration at presentation was lower in patients who underwent MDCT before than after biliary drainage (4.1 ± 5.9 vs. 8.0 ± 7.1 mg/ml, respectively; p = 0.002). Although there were no significant differences in the surgical characteristics or pathological stages between the two groups, R0 resection was more frequently achieved in patients who underwent MDCT before than after biliary drainage [46/64 (72%) vs. 22/44 (50%), respectively; p = 0.03]. On multivariate analysis, MDCT before biliary drainage was independently associated with R0 resection of PHC (risk ratio: 2.38, 95% CI 1.05–5.41; p = 0.04).

Conclusions

In selected patients, MDCT should be performed before biliary drainage to achieve R0 resection of PHC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Miyazaki M, Kato A, Ito H et al (2007) Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141:581–588CrossRef Miyazaki M, Kato A, Ito H et al (2007) Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141:581–588CrossRef
2.
Zurück zum Zitat Shimizu H, Sawada S, Kimura F et al (2009) Clinical significance of biliary vascular anatomy of the right liver for hilar cholangiocarcinoma applied to left hemihepatectomy. Ann Surg 49:435–439CrossRef Shimizu H, Sawada S, Kimura F et al (2009) Clinical significance of biliary vascular anatomy of the right liver for hilar cholangiocarcinoma applied to left hemihepatectomy. Ann Surg 49:435–439CrossRef
3.
Zurück zum Zitat Miyazaki M, Kimura F, Shimizu H et al (2010) One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Sci 17:470–475CrossRef Miyazaki M, Kimura F, Shimizu H et al (2010) One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Sci 17:470–475CrossRef
4.
Zurück zum Zitat Shimizu H, Kimura F, Yoshidome H et al (2010) Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance. Ann Surg 251:281–286CrossRef Shimizu H, Kimura F, Yoshidome H et al (2010) Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance. Ann Surg 251:281–286CrossRef
5.
Zurück zum Zitat Hosokawa I, Shimizu H, Yoshidome H et al (2014) Surgical strategy for hilar cholangiocarcinoma of the left-side predominance: current role of left trisectionectomy. Ann Surg 259:1178–1185CrossRef Hosokawa I, Shimizu H, Yoshidome H et al (2014) Surgical strategy for hilar cholangiocarcinoma of the left-side predominance: current role of left trisectionectomy. Ann Surg 259:1178–1185CrossRef
6.
Zurück zum Zitat Poruk KE, Pawlik T, Weiss MJ (2015) Perioperative management of hilar cholangiocarcinoma. J Gastrointest Surg 19:1889–1899CrossRef Poruk KE, Pawlik T, Weiss MJ (2015) Perioperative management of hilar cholangiocarcinoma. J Gastrointest Surg 19:1889–1899CrossRef
7.
Zurück zum Zitat Unno M, Okumoto T, Katayose Y et al (2007) Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepatobiliary Pancreat Surg 14:434–440CrossRef Unno M, Okumoto T, Katayose Y et al (2007) Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepatobiliary Pancreat Surg 14:434–440CrossRef
10.
Zurück zum Zitat Aloia TA, Charnsangavej C, Faria S et al (2007) High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg 193:702–706CrossRef Aloia TA, Charnsangavej C, Faria S et al (2007) High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg 193:702–706CrossRef
13.
Zurück zum Zitat Fukami Y, Ebata T, Yokoyama Y et al (2012) Diagnostic ability of MDCT to assess right hepatic artery invasion by perihilar cholangiocarcinoma with left-sided predominance. J Hepatobiliary Pancreat Sci 19:179–186CrossRef Fukami Y, Ebata T, Yokoyama Y et al (2012) Diagnostic ability of MDCT to assess right hepatic artery invasion by perihilar cholangiocarcinoma with left-sided predominance. J Hepatobiliary Pancreat Sci 19:179–186CrossRef
14.
Zurück zum Zitat Miyazaki M, Yoshitomi H, Miyakawa S et al (2015) Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci 22:249–273CrossRef Miyazaki M, Yoshitomi H, Miyakawa S et al (2015) Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci 22:249–273CrossRef
15.
Zurück zum Zitat Yoshitomi H, Miyakawa S, Nagino M et al (2015) Updated clinical practice guidelines for the management of biliary tract cancers: revision concepts and major revised points. J Hepatobiliary Pancreat Sci 22:274–278CrossRef Yoshitomi H, Miyakawa S, Nagino M et al (2015) Updated clinical practice guidelines for the management of biliary tract cancers: revision concepts and major revised points. J Hepatobiliary Pancreat Sci 22:274–278CrossRef
16.
Zurück zum Zitat (UICC) International Union Against Cancer (2009) TNM classification of malignant tumors, 7th edn. Wiley, New York (UICC) International Union Against Cancer (2009) TNM classification of malignant tumors, 7th edn. Wiley, New York
17.
Zurück zum Zitat Watanabe Y, Kuboki S, Shimizu H et al (2018) A new proposal of criteria for the future remnant liver volume in older patients undergoing major hepatectomy for biliary tract cancer. Ann Surg 267:338–345CrossRef Watanabe Y, Kuboki S, Shimizu H et al (2018) A new proposal of criteria for the future remnant liver volume in older patients undergoing major hepatectomy for biliary tract cancer. Ann Surg 267:338–345CrossRef
18.
Zurück zum Zitat Tsukahara T, Ebata T, Shimoyama Y et al (2017) Residual carcinoma in situ at the ductal stump has a negative survival effect: an analysis of early-stage cholangiocarcinomas. Ann Surg 266:126–132CrossRef Tsukahara T, Ebata T, Shimoyama Y et al (2017) Residual carcinoma in situ at the ductal stump has a negative survival effect: an analysis of early-stage cholangiocarcinomas. Ann Surg 266:126–132CrossRef
19.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRef
20.
Zurück zum Zitat Nagino M, Ebata T, Yokoyama Y et al (2013) Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg 258:129–140CrossRef Nagino M, Ebata T, Yokoyama Y et al (2013) Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg 258:129–140CrossRef
21.
Zurück zum Zitat Groot Koerkamp B, Wiggers JK, Gonen M et al (2015) Survival after resection of perihilar cholangiocarcinoma: development and external validation of a prognostic nomogram. Ann Oncol 26:1930–1935CrossRef Groot Koerkamp B, Wiggers JK, Gonen M et al (2015) Survival after resection of perihilar cholangiocarcinoma: development and external validation of a prognostic nomogram. Ann Oncol 26:1930–1935CrossRef
22.
Zurück zum Zitat Itoh S, Ikeda M, Ota T et al (2003) Assessment of the pancreatic and intrapancreatic bile ducts using 0.5-mm collimation and multiplanar reformatted images in multislice CT. Eur Radiol 13:277–285PubMed Itoh S, Ikeda M, Ota T et al (2003) Assessment of the pancreatic and intrapancreatic bile ducts using 0.5-mm collimation and multiplanar reformatted images in multislice CT. Eur Radiol 13:277–285PubMed
23.
Zurück zum Zitat Endo I, Matsuyama R, Mori R et al (2014) Imaging and surgical planning for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 21:525–532CrossRef Endo I, Matsuyama R, Mori R et al (2014) Imaging and surgical planning for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 21:525–532CrossRef
24.
Zurück zum Zitat Nagino M (2013) Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. J Gastroenterol 47:1165–1176CrossRef Nagino M (2013) Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. J Gastroenterol 47:1165–1176CrossRef
25.
Zurück zum Zitat Mansour JC, Aloia TA, Crane CH et al (2015) Hilar cholangiocarcinoma: expert consensus statement. HPB 17:691–699CrossRef Mansour JC, Aloia TA, Crane CH et al (2015) Hilar cholangiocarcinoma: expert consensus statement. HPB 17:691–699CrossRef
26.
Zurück zum Zitat Takahashi Y, Nagino M, Nishio H et al (2010) Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg 97:1860–1866CrossRef Takahashi Y, Nagino M, Nishio H et al (2010) Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg 97:1860–1866CrossRef
27.
Zurück zum Zitat Kawakami H, Kuwatani M, Onodera M et al (2011) Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol 46:242–248CrossRef Kawakami H, Kuwatani M, Onodera M et al (2011) Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol 46:242–248CrossRef
28.
Zurück zum Zitat Komaya K, Ebata T, Yokoyama Y et al (2017) Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: a propensity score matching analysis of resectable perihilar cholangiocarcinoma. Surgery 161:394–404CrossRef Komaya K, Ebata T, Yokoyama Y et al (2017) Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: a propensity score matching analysis of resectable perihilar cholangiocarcinoma. Surgery 161:394–404CrossRef
29.
Zurück zum Zitat Hirano S, Tanaka E, Tsuchikawa T et al (2014) Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 21:533–540CrossRef Hirano S, Tanaka E, Tsuchikawa T et al (2014) Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 21:533–540CrossRef
30.
Zurück zum Zitat Sasaki R, Kondo T, Oda T et al (2011) Impact of three-dimensional analysis of multidetector row computed tomography cholangioportography in operative planning for hilar cholangiocarcinoma. Am J Surg 202:441–448CrossRef Sasaki R, Kondo T, Oda T et al (2011) Impact of three-dimensional analysis of multidetector row computed tomography cholangioportography in operative planning for hilar cholangiocarcinoma. Am J Surg 202:441–448CrossRef
31.
Zurück zum Zitat Parikh AA, Abdalla EK, Vauthey JN (2005) Operative considerations in resection of hilar cholangiocarcinoma. HPB 7:254–258CrossRef Parikh AA, Abdalla EK, Vauthey JN (2005) Operative considerations in resection of hilar cholangiocarcinoma. HPB 7:254–258CrossRef
32.
Zurück zum Zitat Rosen CB, Heimbach JK, Gores GJ (2010) Liver transplantation for cholangiocarcinoma. Transpl Int 23:692–697CrossRef Rosen CB, Heimbach JK, Gores GJ (2010) Liver transplantation for cholangiocarcinoma. Transpl Int 23:692–697CrossRef
Metadaten
Titel
Impact of Biliary Drainage on Multidetector-Row Computed Tomography on R0 Resection of Perihilar Cholangiocarcinoma
verfasst von
Isamu Hosokawa
Hiroaki Shimizu
Hideyuki Yoshitomi
Katsunori Furukawa
Tsukasa Takayashiki
Masaru Miyazaki
Masayuki Ohtsuka
Publikationsdatum
11.05.2018
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 11/2018
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-018-4654-2

Weitere Artikel der Ausgabe 11/2018

World Journal of Surgery 11/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.